ARTICLE
Received 26 Mar 2014 | Accepted 21 Nov 2014 | Published 6 Jan 2015
DOI: 10.1038/ncomms6921 OPEN
Antibiotics in ingested human blood affect the mosquito microbiota and capacity to transmit malaria
Mathilde Gendrin1, Faye H. Rodgers1, Rakiswend S. Yerbanga2, Jean Bosco Oudraogo2, Mara-Gloria Basnez3, Anna Cohuet2,4 & George K. Christophides1,5
Malaria reduction is most efciently achieved by vector control whereby human populations at high risk of contracting and transmitting the disease are protected from mosquito bites. Here, we identify the presence of antibiotics in the blood of malaria-infected people as a new risk of increasing disease transmission. We show that antibiotics in ingested blood enhance the susceptibility of Anopheles gambiae mosquitoes to malaria infection by disturbing their gut microbiota. This effect is conrmed in a semi-natural setting by feeding mosquitoes with blood of children naturally infected with Plasmodium falciparum. Antibiotic exposure additionally increases mosquito survival and fecundity, which are known to augment vectorial capacity. These ndings suggest that malaria transmission may be exacerbated in areas of high antibiotic usage, and that regions targeted by mass drug administration programs against communicable diseases may necessitate increased vector control.
1 Department of Life Sciences, Imperial College London, London SW7 2AZ, UK. 2 Institut de Recherche en Sciences de la Sant, 01 BP 545, Bobo-Dioulasso 01, Burkina Faso. 3 Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK. 4 Institut de Recherche pour le Dveloppement, Unit MIVEGEC, 34394 Montpellier, France. 5 The Cyprus Institute, 2121 Nicosia, Cyprus. Correspondence and requests for materials should be addressed to G.K.C. (email: mailto:[email protected]
Web End [email protected] ).
NATURE COMMUNICATIONS | 6:5921 | DOI: 10.1038/ncomms6921 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 1
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6921
Malaria is caused by the parasite Plasmodium, transmitted via bites of Anopheles mosquitoes. Plasmodium game-tocytes ingested with the blood produce gametes that
undergo sexual reproduction inside the mosquito midgut1. Zygotes subsequently traverse the midgut epithelium to develop into oocysts on its basal side. After one to two weeks of multiplicative growth, the oocysts release thousands of sporozoites, which invade the salivary glands and can be transmitted to humans.
Concurrently with parasite uptake and development in the gut lumen, commensal gut bacteria proliferate in response to the blood meal2,3. This microbiota adversely affects parasite development both directly through the production of free radicals and indirectly through the induction of immune responses47. Parasite infection success increases if gut microbial colonisation is prevented throughout mosquito adulthood via feeding with an antibiotic-treated sugar solution5,8. Therefore, we hypothesised that antibiotics present in the blood meal of mosquitoes hosting a conventional microbiota could likewise interfere with bacterial proliferation, thus enhancing mosquito susceptibility to Plasmodium and promoting malaria transmission. Such an effect could considerably inuence the malaria burden in sub-Saharan Africa where the use of antibiotics is high, particularly in areas implementing elimination programs of neglected tropical and other communicable diseases that require the use of antibiotics915.
Here, we tested our hypothesis by supplementing blood with therapeutic concentrations of antibiotics to the mosquito A. gambiae and analysing their effect on the microbiota and on several components of the mosquito vectorial capacity, namely susceptibility to Plasmodium infection, survival rate and fecundity. As our antibiotic model, we chose a cocktail of penicillin and
streptomycin (PS) that is commonly used in mosquito and parasite research without any known effect on mosquitoes or parasites8,1619, has broad antibacterial activity and does not require metabolic activation. We show that exposure of mosquitoes to this antibiotic cocktail signicantly affects their gut microbiota, increases their susceptibility to Plasmodium infection and augments their survival and fecundity. These ndings suggest that PS treatment of Plasmodium gametocyte carriers may increase the risk of malaria transmission.
ResultsEffect of PS on the mosquito gut microbiota. We monitored the bacterial load in the mosquito gut over a time course of three blood feeds offered every three days through an articial skin. Quantitative PCR (qPCR) on the 16S rDNA revealed that the massive proliferation of bacteria seen at 24 h after the blood meal was reduced by 70% (P 0.034, analysis of
variance (ANOVA) test following lmer, see methods) in the presence of PS (Fig. 1a), without any concurrent reduction in blood meal size (Supplementary Fig. 1a). This effect was recurrent upon PS exposure in all three blood meals. The addition of PS to only the rst blood meal, recapitulating a more realistic feeding regimen on antibiotic and non-antibiotic users, did not persistently affect microbiota proliferation after the second and third blood meals (Fig. 1a).
We monitored the composition of the mosquito gut microbiota over a course of two blood feeds by 454-pyrosequencing of the 16S rDNA. The gut microbiota of our A. gambiae colony was dominated by Flavobacteriaceae and Enterobacteriaceae (Fig. 1b), consistent with previous ndings in eld-collected
100
Flavobacteriaceae
Chryseobacterium
Elizabethkingia Cedecea
Enterobacter
Ewingella
Serratia Aeromonas Comamonas Burkholderia AsaiaAll
Enterobacteriaceae
Aeromonadaceae Comamonadaceae
Burkholderiaceae Acetobacteraceae Others
30
C
PS 1st
PS always
90
25
Relative contribution (%)
20
80
Bacterial load
40
15
30
10
20
5
10
0
0
1st BF 2nd BF 3rd BF Time (days after 1st BF)
1 2 3 4 5 6 7 8 9
1st BF 2nd BF time
0 SF
C PS C PS C PS +
+
24 h 72 h 72+24 h
250
500
Bacterial load (%)
450
400
SF
PS
C 24 h after BF
200
Estimated species
(Chao1)
350
300
150
24 h
72 h
72+24 h
C
PS
250
200
100
150
Eubacteria Enterobact.
100
50
50
0
Acetobact.
Flavobact.
0 0 1,000 2,000
Number of reads
SF
24 h
72 h
72+24 h
Figure 1 | Blood meal antibiotics affect mosquito microbiota. (a) qPCR quantication of midgut bacterial 16S rDNA every 24 h during a three blood-feed (BF) course. Blood was supplemented with penicillin/streptomycin (PS always), water (control, C) or PS in the rst blood meal and water thereafter (PS 1st). (b) 16S rDNA 454-pyrosequencing analysis of mosquito gut microbiota before blood meal (sugar fed, SF), 24 and 72 h after PS-treated or untreated blood meal and 24 h after an untreated second blood meal. Main bacterial genera (45% in at least one sample) and families are indicated. (c) Rarefaction curve of the estimated number of species using the Chao1 method. (d) qPCR microbiota analysis using generic or taxon-specic 16S rDNA primers.
Data show average from three (ac) to six (d) independent experiments, error bars show s.e.m., n 1525 mosquitoes per sample and per replicate. qPCR
data show fold versus day 0 (a) and % of control BF. (d) Enterobact.Enterobacteriaceae; Flavobact.Flavobacteriaceae; Acetobact.Acetobacteraceae.
2 NATURE COMMUNICATIONS | 6:5921 | DOI: 10.1038/ncomms6921 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6921 ARTICLE
and laboratory-reared mosquitoes4,2022. A high variability in microbiota composition was recorded between the replicates representing different mosquito batches (Supplementary Fig. 2): 45 of 78 genera were detected in only one of the three replicate experiments, while the relative abundance of genera varied greatly between the replicate samples, including 019.5% and 030.7% for Burkholderia and Cedecea, respectively.
PS supplementation into the blood affected the microbiota composition 24 h after a blood meal (Fig. 1b). Importantly, it halved the within sample microbiota diversity (alpha diversity) (Fig. 1c and Supplementary Table 1), reduced the proportion of Enterobacteriaceae 92-fold (P 0.23, ANOVA/lmer), and led to a
19-fold increase of Acetobacteraceae (P 0.017, ANOVA/lmer)
solely represented by Asaia sp. (Fig. 1b). The effect on Enterobacteriaceae was conrmed by taxon-specic qPCR including more experiments (Fig. 1d; P 0.012, ANOVA/lmer).
The proportion of Flavobacteriaceae was not affected by the PS treatment (Fig. 1b, P 0.79, ANOVA/lmer), which may be linked
to the resistance of Elizabethkingia to PS23. After a second (non-PS treated) blood meal, the decrease in alpha diversity was still observed (Fig. 1c and Supplementary Table 1), but the effects on Enterobacteriaceae and Acetobacteraceae were much reduced (Fig. 1b; threefold decrease, P 0.33, and 8.7% decrease,
P 0.55%, respectively, ANOVA/lmer).
Impact of PS exposure on Plasmodium infectivity. We examined whether the ingestion of PS-containing blood inuences mosquito susceptibility to Plasmodium. Mosquitoes were fed on Plasmodium berghei-infected rodents before or following intravenous injection of PS, and the infection was monitored by counting the proportion of mosquitoes carrying oocysts (prevalence) and the number of oocysts per mosquito (intensity). Prevalence increased by 21% (P 5.10 7, ANOVA/glmer) and
median intensity doubled (P 0.041, 24% of the xed effect
estimate; 108% of the median, Wald/glmmADMB) upon PS
treatment (Fig. 2a,e). No effects on prevalence or intensity were observed when the infection was introduced in the second blood meal following an initial PS-treated non-infectious blood meal (Fig. 2b, e; P 0.5, Wald/glmmADMB). These results are con
sistent with the restoration of control microbiota load and, broadly, population composition following a second, non-PS treated, blood meal (Fig. 1a,b), supporting our hypothesis that the increase in Plasmodium infection is microbiota mediated.
To investigate the effects of PS on infection by human parasites, mosquitoes were fed on blood containing in vitro culturedP. falciparum gametocytes and supplemented with PS or buffer before blood feeding. Consistently with P. berghei infections, higher infection prevalence (P 0.0033, 138%, ANOVA/glmer) and
intensity (P 0.00026, 62% of xed effect estimate, 25%
of the median, Wald/glmmADMB) were recorded when the infectious blood meal was supplemented with PS (Fig. 2c,e).
We examined the implications of these ndings on human malaria transmission in Burkina Faso, in conditions close to eld malaria transmission. A. gambiae from a recently colonised population24 were fed on blood freshly drawn from children carrying P. falciparum gametocytes and supplemented with PS or buffer. Four replicate experiments were performed, each using the blood from a different gametocyte carrier. The obtained data conrmed our rodent model and cultured parasite data and validated our hypothesis that the presence of antibiotics in the blood meal indeed impacts mosquito susceptibility to infection (Fig. 2d,e). The intensity of P. falciparum infection signicantly increased in PS-exposed mosquitoes (P 0.02, 24% of the xed
effect estimate; 57% of the median, Wald/glmmADMB).
A 6.3% increase in infection prevalence was not statistically signicant (P 0.4, ANOVA/glmer), which is likely due to
reduced statistical power of the experiment. It has been shown that whilst prevalence and intensity are clearly linked, effects on prevalence are more pronounced at low infection intensities,
a
b c d
P. falciparum - lab
P. falciparum - field
400
300
P. berghei - 2nd BF
100
200
100
Parasite load (oocysts/gut)
Expt1 Expt2
Expt3 Expt4 Total
50
50
50
40
80
40
40
30
60
30
30
20
40
20
20
10
20
10
10
0
0
0
0
Treatment
P. berghei
C (1st BF) PS (1st BF) 84% 84%
PS
C PS
C
PS
prevalence
C
73% 84%
86% 90%
e
Expt1 Expt2
Expt3
Expt4 Total
1 0.5 0 0.5 1
Expt1 Expt2 Expt3
Total
71% 79%
Expt1 Expt2 Expt3 Expt4 Total
0.5 0 0.5 1
0.5
0.5
0 1
2
0 3
1
Figure 2 | Antibiotics increase mosquito susceptibility to infection by Plasmodium ingested in the same blood meal. (ac) Oocyst counts after PS-treated or control (C) blood meal on P. berghei-infected mice (a), P. falciparum gametocyte cultures (b), naturally infected P. falciparum blood samples (c) and naive mice, followed with a 2nd blood meal on untreated P. berghei-infected mice 3 days later. (d) Medians and oocyst distributions of representative experiments are shown. (e) Forest plots showing the effect of PS treatment on Plasmodium infection intensities in each replicate as determined by GLMM analysis. The variation of the xed effect estimate in each (squares) and all (diamonds) replicates are shown (95% condence interval, glmmADMB). Within each chart, the square size is proportional to the mosquito number. From left to right, charts show the effect on P. berghei, P. falciparumlab,P. falciparumeld and P. berghei2nd BF, respectively. Mosquitoes (n 18205) per experiment and per condition (average 86 (8 s.e.m.)).
NATURE COMMUNICATIONS | 6:5921 | DOI: 10.1038/ncomms6921 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 3
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6921
C
PS always
250
C Naive
PS
PS 1st
200
100
100
CPS P.berghei
Clutch size
(eggs/female)
150
100
Survival (%)
50
Survival (%)
50
50
0
0 0 5 10
Treatment PS
Cegg laying 70%
54%
BF Time (days after BF)
Figure 3 | Blood meal antibiotics increase mosquito survival and fecundity. (a) Mosquito clutch size and percentage of females that laid eggs (Egg laying) following PS-treated or control blood meal. Medians and distributions of egg numbers per female of one representative experiment of three are shown. (b and c) KaplanMaier survival plots of mosquitoes fed on human blood (b) or mice (c). In b, mosquitoes were offered three control blood meals (C), three PS-treated blood meals (PS always), or a PS-treated rst blood meal and two control blood meals (PS 1st). In c, mosquitoes were fed once on P. berghei-infected (solid lines) or naive (dashed lines) mice. Data are pooled from three (b) to four (c) independent experiments. Mosquitoes (n 50) per experiment and per condition.
1st BF 2nd BF 3rd BF
0 0 5 10 15
Time (days after 1st BF)
whereas effects on intensity are irrespective of the exposure level25. The high infection level observed in some of the replicates, averaging up to 29 oocysts in control mosquitoes (Supplementary Table 2), might have therefore masked the effect on prevalence.
Impact of PS exposure on mosquito tness. Mosquito vectorial capacity is not only determined by susceptibility to the malaria parasites; mosquito lifespan, population size and human-biting rate also have strong bearings on malaria prevalence26. We therefore investigated whether the addition of PS to a blood meal inuences mosquito reproduction and survival. Treatment led to increased fecundity (Fig. 3a), including a 32% higher proportion of egg-laying females (P 0.0038, ANOVA/glmer) and a
53% higher average number of eggs per female (P 0.016,
ANOVA/lmer), while the proportion of eggs hatching into larvae was not affected (Supplementary Fig. 1b; P 0.79, ANOVA/
glmer). This increased fecundity is likely to augment the size of mosquito populations, particularly when larval competition in breeding sites is low, notably at the beginning of the rainy season27. The mosquito survival rate also signicantly increased following ingestion of PS-treated human blood (Fig. 3b; P 0.017
for PS in the rst blood meal; P 0.0016 for PS in all three blood
meals, log-rank test), or feeding on PS-treated mice, whether
naive or P. berghei-infected (P 0.0098 and P 0.0029,
respectively, GehanWilcoxon test; Fig. 3c). Increased mosquito survival rate strongly affects vectorial capacity, by increasing the likelihood of infected mosquitoes surviving beyond the parasite extrinsic incubation period (time required between being ingested and becoming infective to humans), and therefore the probability of transmitting the disease to new hosts.
DiscussionOur data show that the presence of PS, a wide-spectrum antibiotic cocktail, in Plasmodium gametocyte-containing blood enhances critical parameters affecting the ability of mosquitoes to transmit malaria, including the mosquito tness and susceptibility to Plasmodium infection. Further epidemiological and modelling studies can quantify the outcome of these effects on malaria transmission. To date, research in aseptic mosquitoes has revealed various benecial effects of microbiota on mosquito physiology; it accelerates development28, protects against Plasmodium and Brugia infections5,8,29 and contributes to nutrition30. Our ndings add a detrimental effect by showing that bacterial multiplication following a blood meal exerts a strong negative
impact on mosquito tness affecting both mosquito survival and fecundity. Thus, although the microbiota is largely benecial to its mosquito host, bacterial growth following a blood meal appears to mimic an oral infection in reducing mosquito tness and, as shown before, inducing an immune response that limits their proliferation5,8. The combination of benecial and detrimental effects of microbiota on its host reects the coexistence of tolerance and resistance mechanisms towards gut bacteria3,5,31, which have both been found to antagonise invasion by malaria parasites3,5.
Sequencing of microbiota revealed that the near clearance of Enterobacteriaceae following PS ingestion correlates with an increase in Acetobacteraceae. This indicates a competition between bacteria taxa in the mosquito gut, where the niche cleared of some bacterial strains by antibiotic treatment is lled by others, as observed in human colon microbiota32. Specically, we observed that Serratia was highly reduced after a PS-containing blood meal, whereas Asaia increased following treatment. These data may be of great relevance to the research towards engineering microbiota to block malaria transmission, as both bacteria are considered good paratransgenesis candidates33,34.
Of the antibiotics used in this study, penicillin inhibits peptidoglycan biosynthesis and targets mostly Gram-positive bacteria35, while streptomycin binds to the bacterial 30S ribosomal subunit, blocking protein synthesis in both Gram-positive and Gram-negative bacteria36. As our Anopheles colony microbiota principally consist of Gram-negative bacteria (only0.17% of the reads belonged to Gram-positive bacteria), it is likely that the effects reported here are largely due to streptomycin. This antibiotic is used in tuberculosis treatments11 and is also part of the World Health Organization Buruli ulcer elimination program12. As Gram-negative bacteria are also dominant in eld mosquitoes20, our data suggest that the extensive use of streptomycin in an area of high malaria endemicity may exaggerate disease transmission. The statistically non-signicant increase of the infection prevalence of eld P. falciparum populations upon PS treatment in our semi-eld experiments, as opposed to the statistically signicant increase in intensity, is likely due to the high infection intensities obtained and not to special attributes of the natural transmission system, where prevalence and intensity are shown to be closely linked. Similarly to the effect on fecundity, streptomycin treatment might impact mosquito infection prevalence early in the rainy season, when the gametocytemia is still low37,38.
Other antibiotics targeting the bacterial 30S ribosomal subunit, including doxycycline, are also commonly used
4 NATURE COMMUNICATIONS | 6:5921 | DOI: 10.1038/ncomms6921 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6921 ARTICLE
in sub-Saharan Africa. Interestingly, doxycycline and azithromycin are used for malaria prophylaxis as they are known to impair Plasmodium asexual development; however, they do not reduce Plasmodium gametocyte numbers39,40 and have no clear direct effect on mosquito stages of Plasmodium development17. Therefore, whilst they reduce malaria morbidity, their overall impact on malaria transmission may require further investigation. Antibiotics such as trimethoprim and sulfamethoxazole directly impair Plasmodium development within the mosquito17 and may negatively or positively inuence malaria transmission depending on the balance between their direct effects on Plasmodium and their indirect, microbiota mediated, effects on Plasmodium and mosquito tness. Our data stresses the need for all these factors to be considered when studying antibiotics as malaria transmission-blocking candidates.
The implications of our ndings for the global effort to reduce malaria transmission depend on the rate of antibiotic usage in malaria-endemic areas. Recent surveys in sub-Saharan African countries estimate antibiotic prescription to feverish children attending health centres at 4371% and to feverish adults at 36% (refs 1315). These frequencies are likely to increase in coming years due to intensied antibiotic treatment of diseases overlapping geographically and seasonally with malaria. Tuberculosis and leprosy patients, as well as HIV/AIDS patients living in high tuberculosis-burden areas, are prescribed long courses of antibiotics10,11, while mass administration of antibiotics for the elimination of neglected tropical diseases, such as mass azithromycin treatments against trachoma, are recommended by the World Health Organization or are currently under investigation9,41,42. Taken together, day-to-day antibiotic usage, long-lasting regimens and mass-targeted treatments result in high antibiotic incidence in human blood and may thus considerably impact malaria transmission.
Antibiotic usage including mass drug administration is shown to signicantly reduce childhood mortality in malaria-endemic countries43. Our data suggest that understanding the impact of these antibiotics on malaria transmission may add signicant value to such treatments. For example, prescription of an antibiotic shown to enhance malaria transmission could be combined with a recommendation for increased bednet usage, further reducing the exposure to mosquito bites. Such antibiotics could be alternatively co-prescribed with drugs such as atovaquone42, which not only combat malaria infection but also block its transmission. This is especially true for young children that are both highly vulnerable to malaria infection and very efcient at transmitting the parasite to mosquitoes37. If possible, antibiotics that do not promote or even prevent malaria transmission could be prioritised.
Methods
Ethics statement. All experiments performed in the United Kingdom were carried out in accordance with the United Kingdom Animals (Scientic Procedures) Act 1986. The protocol for infecting mosquitoes with P. berghei by blood feeding on parasite-infected mice was approved and carried out under the UK Home Ofce License PPL70/7185 awarded in January 2010. The procedures are of mild to moderate severity and the numbers of animals used are minimised by incorporation of the most economical protocols. Opportunities for reduction, renement and replacement of animal experiments are constantly monitored and new protocols are implemented following approval by the Imperial College Ethical Review Committee.
All experiments performed in Burkina Faso were carried out in accordance with guidelines of the Centre Muraz Institutional Ethics Committee. The protocols for mosquito maintenance and for human blood collection were approved by the Centre Muraz Institutional Ethics Committee under the ethical clearance number 003-2009/cE-cM. Before enrollment, written informed consent was taken from each human volunteer and/or their legal guardian.
Mosquito colony and maintenance. Most experiments were performed with female mosquitoes from an M form A. gambiae Ngousso colony, established from
eld mosquitoes collected in Cameroon in 2006, maintained on human blood and fed as adults with 5% fructose. The eld parasite infections were performed with female mosquitoes from an S form A. gambiae colony established from eld mosquitoes collected in Burkina Faso in 200924, maintained on rabbit blood and fed as adults with 5% glucose. Larvae were fed tetramin sh food. Insectary temperature was maintained at 28 C (1 C), 7080% humidity on a 12 h light/ dark cycle.
Human blood feeding and Plasmodium infections. P. falciparum NF54 game-tocytes were cultured in Roswell Park Memorial Institute medium supplemented with 50 mg l 1 hypoxanthine, 10% heat-inactivated human serum in the absence of antibiotics. Two 25 ml cultures were started 14 and 17 days before the infection with 6% v/v washed O red blood cells (RBCs) infected at 0.5% and media was changed every day. Before mosquito infection, centrifuged RBCs were pooled and supplemented with fresh RBCs and human serum (nal concentrations: 32% cultured RBCs, 8% fresh RBCs, 60% serum). For experiments carried out from eld parasites, gametocyte carriers were selected among 514-year-old school children in Burkina Faso. Vein blood was sampled into a lithium-heparin coated tube and serum was replaced by European AB serum to reduce the chance of transmission-blocking immunity. Mosquitoes were offered a blood meal from a membrane-feeding device covered with paralm and kept at 37 C. Twenty microlitres of a cocktail containing 1,000 mg ml 1 streptomycin plus 1,000 U ml 1 penicillin (Sigma) was added to1 ml of blood. The nal streptomycin concentration in the blood (20 mg ml 1) is chosen as a proxy to the average therapeutic concentration upon treatment44,45, while the concentration of penicillin (20 U ml 1) is within the recommended range of therapeutic concentrations that vary substantially46. Control blood was supplemented with 20 ml of water. For P. berghei infections, 812-week-old TO female mice were intraperitoneally injected with 100 ml EF1 P. berghei-infected blood. Two days later, a group of four to ve mice with 38% parasitemia was anaesthetised by 4 ml g 1 intramuscular injection of Rompun (0.33%) and ketamine (33 mg ml 1) in PBS and used to blood feed a group of mosquitoes for 1015 min.
To reduce the mice inter-individual effects, the same mice were intravenously injected with 2 mg g 1 streptomycin, 2 U g 1 penicillin, left for 10 min for antibiotic diffusion in the bloodstream (20 mg ml 1 streptomycin, 20 U ml 1 penicillin after diffusion in a volume of 92 ml kg 1 of blood47) and used to feed a second group of mosquitoes for 1015 min. For each Plasmodium infection, at least 100 mosquitoes per condition were offered a blood meal and non-engorged mosquitoes were removed. All mosquitoes that blood fed and survived until the end of the experiment were dissected for oocyst counts using mercurochrome staining (P. falciparum) or uorescence (P. berghei). On average, the oocysts of 86(8 s.e.m.) mosquitoes per condition per experiment were counted.
Microbiota analysis by qPCR. Non-blood-fed mosquitoes were discarded after the blood meal. Before dissection, mosquitoes were immersed in 75% ethanol for 5 min to kill mosquitoes and to x surface bacteria to the cuticle. Mosquitoes were then washed three times in sterile PBS to wash out non-attached bacteria, thus preventing sample contamination with cuticle bacteria during dissection. Midguts were removed and frozen immediately on dry ice in three groups of at least ve mosquitoes per condition and stored at 20 C until processing. Midguts were
only excluded from analysis if they burst and that a substantial amount of the gut content was lost. Samples were homogenised with 0.5-mm wide glass beads (Bertin) for 30 s at 6,800 r.p.m. in a Precellys 24 homogenizer (Bertin) in phenol chloroform and DNA was extracted with phenolchloroform. The 16S rDNA was used for bacterial quantication and is shown as a ratio of the Anopheles housekeeping gene 40S ribosomal protein S7 (VectorBase gene ID AGAP010592), referred to as S7. Primer sequences are listed in Supplementary Table 3. qPCR was performed on a 7,500 Fast Real-Time thermocycler (Applied Biosystems) using the SYBR Premix Ex Taq kit (Takara), following the manufacturers instructions.
Microbiota analysis by 454-pyrosequencing. Mosquitoes were treated as for qPCR analysis, with special care to reduce risks of contamination: dissecting slides and forceps were washed with detergent, rinsed with water and then with ethanol between each sample and sample-containing tubes were ultraviolet pretreated. At least 15 mosquitoes per condition were dissected. A contamination control was included, where drops of PBS were left on a dissecting slide and then transferred 10 times with forceps into the tube to mimic dissection routine. DNA extraction conditions were chosen according to Yuan et al.48 to sample the microbiota composition as accurately as possible. Samples were homogenised for 15 s in a lysis buffer (20 mM Tris pH 8.0, 2 mM EDTA, 1.2% Triton 20 mg ml 1 lysozyme, 250 U ml 1 mutanolysin and 20 U ml 1 lysostaphin), incubated for 30 min at37 C and homogenised again for 15 s. DNA was extracted using a DNeasy blood and tissue kit (Qiagen) under sterile conditions. qPCR conrmed that this extraction method provided a similar pattern of bacterial growth that is reduced in presence of PS as seen with phenolchloroform (Fig. 1a, Supplementary Fig. 3). The regions V2-V3 of the 16S rDNA were amplied using 16S0027F (50-AGAG
TTTGATCCTGGCTCAG-30) and 16S0533R (50-TTACCGCGGCTGCTGG CAC-30) attached in 50 to Roche MID adapters (Supplementary Table 4) with Phusion polymerase (New England Biolabs; 27 cycles: 5 s at 98 C, 20 s at 63 C, 20 s at 72 C, followed by 5 min at 72 C). After Picogreen (Life Technologies)
NATURE COMMUNICATIONS | 6:5921 | DOI: 10.1038/ncomms6921 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 5
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6921
quantication, a pool of 48 samples (including the 24 samples reported here), each of 50 ng DNA, was 454-pyrosequenced49 using a half run of a 454 GS FLX sequencer (Roche) by Beckman Coulter Genomics. Sequencing resulted in 544038 sequences processed with Qiime50 (version 1.8.0). Of these, 177287 reads of 477 bp average length after primer truncation were assigned to the 24 samples (no primer mismatch allowed), and 175627 of them were identied as non-chimeric using usearch6151 (see Supplementary Table 4 for details on each sample). operational taxonomic units (OTUs) were picked using uclust software with a 97% identity threshold51. Among the contamination controls, one replicate produced only 12 reads after ltering; the other two were signicantly different from mosquito gut samples (ANOSIM test output P 0.024 and P 0.004 on weighted and
unweighted Unifrac distances52, respectively) and were thus excluded from subsequent analyses. Alpha diversity was quantied using the number of observed species, the Chao1 species richness estimation53, the Shannon index and the phylogenetic diversity whole-tree index54 (Supplementary Table 1). OTUs were assigned to taxonomy against the Silva reference data set (Release 119)55. Principal coordinates analysis was performed using Emperor56.
Blood meal size quantication. Individual females were housed in plastic vials after blood feeding and allowed to deposit their faecal pellets. All excreted material was dissolved in 1 ml 1% lithium carbonate solution and the absorbance measured at 387 nm57. The quantity of haematin in each faecal pellet was calculated by comparison with a standard curve constructed with porcine serum haematin (Sigma). At least eight mosquitoes per condition were used for each replicate.
Survival. Age-matched 26-day-old mosquitoes were offered a control or experimental blood meal once (Fig. 3c) or every 4 days (Fig. 3b) for a total of three blood meals. Between the blood meals, mosquitoes were provided with a cotton pad moistened with distilled water for oviposition. Unfed mosquitoes were removed after each blood meal and excluded from data analysis. This did not impact survival data, as blood treatment did not signicantly affect the number of unfed mosquitoes after the second and third blood meals (P 0.60, ANOVA/
glmer). Deaths were counted and carcasses removed on a daily basis. At least 50 mosquitoes per condition were used for each replicate.
Fecundity and fertility. Blood-fed mosquitoes were stored in individual cups with lter paper moistened with distilled water for oviposition. For fecundity analyses, eggs were counted upon laying. Females that had not laid eggs after at least 6 days were considered non-egg layers. For fertility analyses, eggs were counted and oated in salt water. Larvae were counted and removed on a daily basis. Any egg remaining after 1 week was considered unhatched. At least 50 mosquitoes per condition were used for each replicate.
Statistical analyses. Statistical analyses were performed by generalized linear mixed models (GLMM) in R (version 2.15.3). Factorial data (prevalence, egg laying and proportion of unfed mosquitoes for survival experiments) were analysed by ANOVA w2-test on a logistic regression (glmer). Oocyst counts were analysed by
Wald Z-test on a zero-inated negative binomial regression (glmmADMB). 16S data (qPCR, alpha diversity, family relative abundance from pyrosequencing) and egg counts were analysed by ANOVA w2-test on a common linear regression (lmer). GLMM analyses decompose model effects into the contribution of a xed component (the covariates in question, here treatments) and a random component (here experiments for each treatment). The xed effect estimates are the regression coefcients. For infection intensity we report both the xed effects and the variations in the median number of oocysts per mosquito. Human and mouse blood meal survival data were analysed using a log-rank test and a GehanWilcoxon test, respectively, to reect the experimental setup where human blood meals are given throughout the experiment and a mouse blood meal only on the rst day. In both the cases, survival tests were stratied by experimental replicate. All differences between PS-treated and control mosquitoes are calculated as means of all proportional changes in the independent replicates; that is, (data(PS) data(control))/
data(control) expressed as a percentage. Sample size was chosen according to the standard protocols (oocyst counts, blood meal quantication, survival, fecundity and fertility) or following preliminary tests on individual mosquitoes (microbiota analyses). Mosquitoes were excluded if they did not blood feed, if they burst during dissection (microbiota analyses) or if they died during the experiment (except for survival experiments).
References
1. Vlachou, D., Schlegelmilch, T., Runn, E., Mendes, A. & Kafatos, F. C. The developmental migration of Plasmodium in mosquitoes. Curr. Opin. Genet. Dev. 16, 384391 (2006).
2. Pumpuni, C. B., Demaio, J., Kent, M., Davis, J. R. & Beier, J. C. Bacterial population dynamics in three anopheline species: the impact on Plasmodium sporogonic development. Am. J. Trop. Med. Hyg. 54, 214218 (1996).
3. Kumar, S., Molina-Cruz, A., Gupta, L., Rodrigues, J. & Barillas-Mury, C. A peroxidase/dual oxidase system modulates midgut epithelial immunity in Anopheles gambiae. Science 327, 16441648 (2010).
4. Gendrin, M. & Christophides, G. K. in Anopheles mosquitoes - New insights into malaria vectors (ed Manguin, S.) 10.5772/55107 (InTech, 2013).
5. Meister, S. et al. Anopheles gambiae PGRPLC-mediated defense against bacteria modulates infections with malaria parasites. PLoS Pathog. 5, e1000542 (2009).
6. Cirimotich, C. M. et al. Natural microbe-mediated refractoriness to Plasmodium infection in Anopheles gambiae. Science 332, 855858 (2011).
7. Rodrigues, J., Brayner, F. A., Alves, L. C., Dixit, R. & Barillas-Mury, C. Hemocyte differentiation mediates innate immune memory in Anopheles gambiae mosquitoes. Science 329, 13531355 (2010).
8. Dong, Y., Manfredini, F. & Dimopoulos, G. Implication of the mosquito midgut microbiota in the defense against malaria parasites. PLoS Pathog. 5, e1000423 (2009).
9. Solomon, A. W. et al. Trachoma control: a guide for programme managers. (eds World Health Organisation, London School of Hygiene and Tropical Medicine, International Trachoma Initiative). http://whqlibdoc.who.int/publications/2006/9241546905_eng.pdf
Web End =http://whqlibdoc.who.int/ http://whqlibdoc.who.int/publications/2006/9241546905_eng.pdf
Web End =publications/2006/9241546905_eng.pdf (2006).
10. World Health Organisation. Model Prescribing Information. Drugs used in Leprosy. http://apps.who.int/medicinedocs/pdf/h2988e/h2988e.pdf
Web End =http://apps.who.int/medicinedocs/pdf/h2988e/h2988e.pdf (1998).
11. World Health Organisation. Treatment of Tuberculosis Guidelines. 4th Edition http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf
Web End =http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf (2010).
12. World Health Organisation. Buruli ulcer (Mycobacterium ulcerans infection). in Fact sheet http://www.who.int/mediacentre/factsheets/fs199/en/
Web End =http://www.who.int/mediacentre/factsheets/fs199/en/ (2013).
13. Batwala, V., Magnussen, P. & Nuwaha, F. Antibiotic use among patients with febrile illness in a low malaria endemicity setting in Uganda. Malar. J. 10, 377 (2011).
14. Sievers, A. C. et al. Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of community-based malaria control programme in rural Rwanda. Malar. J. 7, 167 (2008).
15. Vialle-Valentin, C. E., Lecates, R. F., Zhang, F., Desta, A. T. & Ross-Degnan, D. Predictors of antibiotic use in African communities: evidence from medicines household surveys in ve countries. Trop. Med. Int. Health 17, 211222 (2012).
16. Sinden, R. E., Hartley, R. H. & Winger, L. The development of Plasmodium ookinetes in vitro: an ultrastructural study including a description of meiotic division. Parasitology 91(Pt 2): 227244 (1985).
17. Delves, M. et al. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Med. 9, e1001169 (2012).
18. Garver, L. S. et al. Anopheles Imd pathway factors and effectors in infection intensity-dependent anti-Plasmodium action. PLoS Pathog. 8, e1002737 (2012).
19. Bando, H. et al. Intra-specic diversity of Serratia marcescens in Anopheles mosquito midgut denes Plasmodium transmission capacity. Sci. Rep. 3, 1641 (2013).
20. Osei-Poku, J., Mbogo, C. M., Palmer, W. J. & Jiggins, F. M. Deep sequencing reveals extensive variation in the gut microbiota of wild mosquitoes from Kenya. Mol. Ecol. 21, 51385150 (2012).
21. Wang, Y., Gilbreath, 3rd T. M., Kukutla, P., Yan, G. & Xu, J. Dynamic gut microbiome across life history of the malaria mosquito Anopheles gambiae in Kenya. PLoS One 6, e24767 (2011).
22. Boissiere, A. et al. Midgut microbiota of the malaria mosquito vector Anopheles gambiae and interactions with Plasmodium falciparum infection. PLoS Pathog. 8, e1002742 (2012).
23. Akhouayri, I. G., Habtewold, T. & Christophides, G. K. Melanotic pathology and vertical transmission of the gut commensal Elizabethkingia meningoseptica in the major malaria vector Anopheles gambiae. PLoS One 8, e77619 (2013).
24. Mouline, K. et al. Physiology and development of the M and S molecular forms of Anopheles gambiae in Burkina Faso (West Africa). Med. Vet. Entomol. 26, 447454 (2012).
25. Churcher, T. S. et al. Measuring the blockade of malaria transmission-an analysis of the standard membrane feeding assay. Int. J. Parasitol. 42, 10371044 (2012).
26. Smith, D. L. & McKenzie, F. E. Statics and dynamics of malaria infection in Anopheles mosquitoes. Malar. J. 3, 13 (2004).
27. White, M. T. et al. Modelling the impact of vector control interventions on Anopheles gambiae population dynamics. Parasit. Vectors 4, 153 (2011).
28. Chouaia, B. et al. Delayed larval development in Anopheles mosquitoes deprived of Asaia bacterial symbionts. BMC Microbiol. 12(Suppl 1): S2 (2012).
29. Nayar, J. K. & Knight, J. W. Nutritional factors and antimicrobials on development of infective larvae of subperiodic Brugia malayi (Nematoda: Filarioidea) in Anopheles quadrimaculatus and Aedes aegypti (Diptera: Culicidae). J. Med. Entomol. 28, 275279 (1991).
30. Jadin, J. [Role of bacteria in the digestive tube of insects, vectors of plasmodidae and trypanosomidae]. Ann. Soc. Belges. Med. Trop. Parasitol. Mycol. 47, 331342 (1967).
31. Stathopoulos, S., Neafsey, D. E., Lawniczak, M. K., Muskavitch, M. A. & Christophides, G. K. Genetic Dissection of Anopheles gambiae Gut Epithelial Responses to Serratia marcescens. PLoS Pathog. 10, e1003897 (2014).
32. Rea, M. C. et al. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difcile and microbial diversity in a model of the distal colon. Proc. Natl Acad. Sci. USA 108(Suppl 1): 46394644 (2011).
6 NATURE COMMUNICATIONS | 6:5921 | DOI: 10.1038/ncomms6921 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6921 ARTICLE
33. Favia, G. et al. Bacteria of the genus Asaia stably associate with Anopheles stephensi, an Asian malarial mosquito vector. Proc. Natl Acad. Sci. USA 104, 90479051 (2007).
34. Riehle, M. A., Srinivasan, P., Moreira, C. K. & Jacobs-Lorena, M. Towards genetic manipulation of wild mosquito populations to combat malaria: advances and challenges. J. Exp. Biol. 206, 38093816 (2003).
35. Waxman, D. J. & Strominger, J. L. Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics. Annu. Rev. Biochem. 52, 825869 (1983).
36. Grifn, M. O., Fricovsky, E., Ceballos, G. & Villarreal, F. Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am. J. Physiol. Cell Physiol. 299, C539C548 (2010).
37. Churcher, T. S. et al. Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection. eLife 2, e00626 (2013).
38. Paul, R. E., Diallo, M. & Brey, P. T. Mosquitoes and transmission of malaria parasites - not just vectors. Malar. J. 3, 39 (2004).
39. Tan, K. R., Magill, A. J., Parise, M. E. & Arguin, P. M. Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. Am. J. Trop. Med. Hyg. 84, 517531 (2011).
40. Bregani, E. R., Tien, T. V., Monzani, V., Figini, G. & Manenti, F. Azithromycin in the treatment of Plasmodium falciparum gametocytes. Preliminary observation. Panminerva Med. 42, 197199 (2000).
41. Mitja, O. et al. Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial. Lancet 379, 342347 (2012).
42. Taylor, M. J. et al. Macrolaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial. Lancet 365, 21162121 (2005).
43. Keenan, J. D. et al. Childhood mortality in a cohort treated with mass azithromycin for trachoma. Clin. Infect Dis. 52, 883888 (2011).
44. Schulz, M. & Schmoldt, A. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 58, 447474 (2003).
45. PDRNetwork. Streptomycin - Drug summary. In: Physicians Desk Reference http://www.pdr.net/drug-summary/streptomycin?druglabelid=1600
Web End =http://www.pdr.net/drug-summary/streptomycin?druglabelid=1600 (2014).
46. PDRNetwork. Penicillin G potassium - Drug summary. in Physicians Desk Reference http://www.pdr.net/drug-summary/penicillin-g-potassium?druglabelid=1150
Web End =http://www.pdr.net/drug-summary/penicillin-g-potassium? http://www.pdr.net/drug-summary/penicillin-g-potassium?druglabelid=1150
Web End =druglabelid=1150 (2014).
47. Riches, A. C., Sharp, J. G., Thomas, D. B. & Smith, S. V. Blood volume determination in the mouse. J. Physiol. 228, 279284 (1973).
48. Yuan, S., Cohen, D. B., Ravel, J., Abdo, Z. & Forney, L. J. Evaluation of methods for the extraction and purication of DNA from the human microbiome. PLoS One 7, e33865 (2012).
49. Ronaghi, M., Uhlen, M. & Nyren, P. A sequencing method based on real-time pyrophosphate. Science 281, 363 365 (1998).
50. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335336 (2010).
51. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 24602461 (2010).
52. Lozupone, C. & Knight, R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71, 82288235 (2005).
53. Bunge, J., Willis, A. & Walsh, F. Estimating the number of species in microbial diversity studies. Annu. Rev. Stat. Appl. 1, 427445 (2014).
54. Faith, D. P. & Baker, A. M. Phylogenetic diversity (PD) and biodiversity conservation: some bioinformatics challenges. Evol. Bioinform. Online 2, 121128 (2006).
55. Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590D596 (2013).
56. Vazquez-Baeza, Y., Pirrung, M., Gonzalez, A. & Knight, R. EMPeror: a tool for visualizing high-throughput microbial community data. GigaScience 2, 16 (2013).
57. Briegel, H. Determination of uric-acid and hematin in a single sample of excreta from blood-fed insects. Experientia 36, 14281428 (1980).
Acknowledgements
We thank Katarzyna Sala, Raymond Hien, Jean Bazi and Eugene Lee for technical help; Noushin Emami, Mara Lawniczak, Jewelna Osei-Poku for technical advice; gametocyte carriers for blood donation; Kevin Baird, Michael Povelones and Robert M. Waterhouse for critical reading. The work was funded by the European Commission HEALTH-F3-2008-223736 Collaborative Project TransMalariaBloc and the BBSRC Project BB/ K009338/1 to GKC, and a BBSRC-DTG PhD studentship to FHR.
Author contributions
M.G., F.H.R., A.C. and G.K.C. designed the experiments. M.G. and F.H.R. performed the experiments. A.C., R.S.Y. and J.B.O. provided infrastructure and organised gametocyte carrier recruitment in Burkina Faso. M.-G.B. provided intellectual input and advised on the statistical analyses. M.G. and G.K.C. wrote the manuscript. F.H.R. and M.-G.B. commented on the manuscript. All the authors revised the manuscript and approved the nal version.
Additional information
Accession codes: The 16S sequencing data have been deposited in the European Nucleotide Archive under accession code PRJEB7708.
Supplementary Information accompanies this paper at http://www.nature.com/naturecommunications
Web End =http://www.nature.com/ http://www.nature.com/naturecommunications
Web End =naturecommunications
Competing nancial interests: The authors declare no competing nancial interests.
Reprints and permission information is available online at http://npg.nature.com/reprintsandpermissions/
Web End =http://npg.nature.com/ http://npg.nature.com/reprintsandpermissions/
Web End =reprintsandpermissions/
How to cite this article: Gendrin, M. et al. Antibiotics in ingested human bloodaffect the mosquito microbiota and capacity to transmit malaria. Nat. Commun. 6:5921 doi: 10.1038/ncomms6921 (2015).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the articles Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Web End =http://creativecommons.org/licenses/by/4.0/
NATURE COMMUNICATIONS | 6:5921 | DOI: 10.1038/ncomms6921 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 7
& 2015 Macmillan Publishers Limited. All rights reserved.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Nature Publishing Group Jan 2015
Abstract
Malaria reduction is most efficiently achieved by vector control whereby human populations at high risk of contracting and transmitting the disease are protected from mosquito bites. Here, we identify the presence of antibiotics in the blood of malaria-infected people as a new risk of increasing disease transmission. We show that antibiotics in ingested blood enhance the susceptibility of Anopheles gambiae mosquitoes to malaria infection by disturbing their gut microbiota. This effect is confirmed in a semi-natural setting by feeding mosquitoes with blood of children naturally infected with Plasmodium falciparum. Antibiotic exposure additionally increases mosquito survival and fecundity, which are known to augment vectorial capacity. These findings suggest that malaria transmission may be exacerbated in areas of high antibiotic usage, and that regions targeted by mass drug administration programs against communicable diseases may necessitate increased vector control.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer